Literature DB >> 1810600

An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.

P Dorigo1, R M Gaion, P Belluco, L Mosti, P A Borea, I Maragno.   

Abstract

1. It has been reported previously that the milrinone analogues, ethyl 5-cyano-1,6-dihydro-2-methyl-6-oxo-3 pyridine carboxylate (I) and ethyl 5-cyano-1,6-dihydro-2-ethyl-6-oxo-3 pyridine carboxylate (II) exert a positive inotropic effect (EC50 = 15.6 +/- 0.2 microM and 40.3 +/- 0.1 microM) both on spontaneously beating and on electrically driven atria from reserpine-treated guinea-pigs. In the present study the mechanism of the inotropic action of these two agents was investigated. 2. In electrically driven left atrium from reserpine-treated guinea-pigs the EC50 values for inotropic activity for compounds (I) and (II) corresponded to that of milrinone (EC50 = 25 +/- 0.1 microM) but compound (I) induced a greater maximum effect. This corresponded to a percentage increase in developed tension over control of 63 +/- 0.3 whereas the maximum inotropic effect of milrinone was 48 +/- 0.3 and that of compound (II) was 47 +/- 0.2. 3. The inotropic activity of compounds (I) and (II) (10-100 microM) was resistant to propranolol (0.1 microM), thus excluding the involvement of beta-adrenoceptors. 4. Since the inotropism induced by compounds (I) and (II) was not reduced by carbachol (1 nM-0.5 microM), an action involving changes in adenosine 3':5'-cyclic monophosphate (cyclic AMP) can be excluded. 5. The inotropic action of compounds (I) and (II) was blocked selectively by 8-phenyltheophyline (10 microM) or adenosine deaminase (2 u ml-1). 6. Both (I) and (II) inhibited, in an apparently competitive manner, the negative inotropic effect induced by N6-(L-phenylisopropyl) adenosine (L-PIA), a stable adenosine agonist. The pA2 values for (I) and (II) were 4.79 and 4.36, respectively.7. In rat brain compounds (I) and (II) inhibited the specific binding of N6-cyclohexyl[3H]-adenosine- ([3H]-CHA) with an IC50 of 0.18 + 0.01 mM and 0.25 + 0.02 mm, respectively, which were similar to their IC50 values for blocking the PIA-induced negative inotropic effect and which are also in the range of concentrations that are effective in inducing positive inotropism in guinea-pig atria.8. The results from the present study suggest that antagonism of endogenous purines causes positive inotropism without affecting intracellular cyclic AMP levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810600      PMCID: PMC1908841          DOI: 10.1111/j.1476-5381.1991.tb12519.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

Authors:  W S Colucci; R F Wright; E Braunwald
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

2.  Involvement of purine compounds in the inotropic action of milrinone.

Authors:  P Dorigo; R M Gaion; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

3.  Hydroxylated chlorpromazine metabolites: positive inotropic action and the release of catecholamines.

Authors:  K Temma; T Akera; T M Brody
Journal:  Mol Pharmacol       Date:  1977-11       Impact factor: 4.436

4.  Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.

Authors:  C Q Earl; J Linden; W B Weglicki
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

Review 5.  Adenosine receptors: targets for future drugs.

Authors:  J W Daly
Journal:  J Med Chem       Date:  1982-03       Impact factor: 7.446

6.  Correlation of cyclic AMP and cyclic GMP levels with changes in contractile force of dog ventricular myocardium during cholinergic antagonism of positive inotropic actions of histamine, glucagon, theophylline and papaverine.

Authors:  M Endoh
Journal:  Jpn J Pharmacol       Date:  1979-12

7.  Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.

Authors:  M Endoh; S Yamashita; N Taira
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

8.  Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance.

Authors:  L Belardinelli; G Isenberg
Journal:  Am J Physiol       Date:  1983-05

9.  Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine.

Authors:  M Ito; T Tanaka; M Saitoh; H Masuoka; T Nakano; H Hidaka
Journal:  Biochem Pharmacol       Date:  1988-05-15       Impact factor: 5.858

10.  The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.

Authors:  W J Parsons; V Ramkumar; G L Stiles
Journal:  Mol Pharmacol       Date:  1988-04       Impact factor: 4.436

View more
  1 in total

1.  New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.

Authors:  M Floreani; P Fossa; S Gessi; L Mosti; P A Borea; P Dorigo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.